An Open-label, Parallel-group Study to Determine the Single and Multiple Dose Pharmacokinetics of Elinogrel and Its Metabolite in Patients With Mild, Moderate, and Severe Renal Impairment Compared to Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 23 Nov 2010
At a glance
- Drugs Aspirin; Elinogrel
- Indications Embolism and thrombosis; Renal impairment
- Focus Pharmacokinetics
- 23 Nov 2010 Primary endpoints identified as reported by ClinicalTrials.gov.
- 23 Nov 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 23 Sep 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.